As of 27 January 2026, several field safety notices have been issued, affecting various medical devices.…
Category: Regulatory Affairs
Global updates on medical device regulation and quality.
Swissmedic Approves Extension of Therapeutic Indication for Hepcludex
On January 27, 2026, Swissmedic announced the extension of the therapeutic indication for Hepcludex, a medication…
Mercury Pharmaceuticals Ltd Issues Precautionary Recall of Paliperidone Pre-Filled Syringes Due to GMP Deficiencies
Published on 2026-01-26T18:30:14.000Z, a significant recall alert has been issued by Mercury Pharmaceuticals Ltd. The company…
Glenmark Pharmaceuticals Europe Limited Issues Precautionary Recall of Fingolimod Glenmark 0.5 mg Hard Capsules
Meta description: Glenmark Pharmaceuticals Europe Limited recalls Fingolimod Glenmark 0.5 mg Hard Capsules due to stability…
Medical Device Field Safety Notices Issued from 12 to 16 January 2026
As of 22 January 2026, a series of field safety notices were issued for medical devices…
Olympus Expands Recall of ViziShot 2 FLEX Needles Over Patient Safety Concerns
January 17, 2026 Olympus Corporation has expanded its global medical device removal action for ViziShot 2…
Swissmedic Expands Indication for Amvuttra
Published January 26, 2026 The Swiss Agency for Therapeutic Products (Swissmedic) announced an extension of the…
Swissmedic Introduces New Requirements for Integral Combination Products
On January 21, 2026, Swissmedic announced new requirements for the authorization of medicinal products with integral…
Swissmedic Batch Recall of Risperidon-Mepha LA Injection
What Changed? As of January 22, 2026, Swissmedic announced a batch recall of Risperidon-Mepha LA Pulver…